Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HAART' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 266 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Raulin, J
      Human immunodeficiency virus and host cell lipids. Interesting pathways inresearch for a new HIV therapy

      PROGRESS IN LIPID RESEARCH
    2. Salmaggi, A; Maccagnano, E; Castagna, A; Zeni, S; Fantini, F; Cinque, P; Savoiardo, M
      Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy

      NEUROLOGICAL SCIENCES
    3. Gerna, G; Piccinini, G; Genini, E; Percivalle, E; Zavattoni, M; Lilleri, D; Testa, L; Comolli, G; Maserati, T; Baldanti, F; Maccario, R; Monforte, AD; Revello, MG
      Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Hsu, LC; Vittinghoff, E; Katz, MH; Schwarcz, SK
      Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Servais, J; Nkoghe, T; Schmit, JC; Arendt, V; Robert, I; Staub, T; Moutschen, M; Schneider, F; Hemmer, R
      HIV-associated hematologic disorders are correlated with plasma viral loadand improve under highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Carrieri, P; Cailleton, V; Le Moing, V; Spire, B; Dellamonica, P; Bouvet, E; Raffi, F; Journot, V; Moatti, JP
      The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Beinker, NK; Mayers, DL; Lange, CG; Valdez, H; Sitkins, J; Lemonnier, L; Chowdhry, TK; Lederman, MM
      Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Sackoff, JE; Shin, SS
      Trends in immunologic and clinical status of newly diagnosed HIV-positive patients initiating care in the HAART era

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
      Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Rompalo, AM; Shah, N; Mayer, K; Schuman, T; Klein, RS; Smith, DK; Vlahov, D
      Influence of injection drug use behavior on reported antiretroviral therapy use among women in the HIV epidemiology research study: On-site versus referral care

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
      Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
      Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Leng, QB; Borkow, G; Weisman, Z; Stein, M; Kalinkovich, A; Bentwich, Z
      Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Bogner, JR; Vielhauer, V; Beckmann, RA; Michl, G; Wille, L; Salzberger, B; Goebel, FD
      Stavudine versus zidovudine and the development of lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Tarwater, PM; Margolick, JB; Jin, JH; Phair, JP; Detels, R; Rinaldo, C; Giorgi, J; Munoz, A
      Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Keiser, P; Nassar, N; Kvanli, MB; Turner, D; Smith, JW; Skiest, D
      Long-term impact of highly active antiretroviral therapy on HIV-related health care costs

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Lewden, C; Raffi, F; Chene, G; Sobel, A; Leport, C
      Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy - Standardization to the general population

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Girardi, E; Palmieri, F; Cingolani, A; Ammassari, A; Petrosillo, N; Gillini, L; Zinzi, D; De Luca, A; Antinori, A; Ippolito, G
      Changing clinical presentation and survival in HIV-associated tuberculosisafter highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    19. Dorrucci, M; Suligoi, B; Serraino, D; Tirelli, U; Rezza, G
      Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    20. Tchetgen, E; Kaplan, EH; Friedland, GH
      Public health consequences of screening patients for adherence to highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    21. Abgrall, S; Matheron, S; Le Moing, V; Dupont, C; Costagliola, D
      Pneumocystis carinii pneumonia recurrence in HIV patients on highly activeantiretroviral therapy: Secondary prophylaxis

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. Moore, AL; Mocroft, A; Madge, S; Devereux, H; Wilson, D; Phillips, AN; Johnson, M
      Gender differences in virologic response to treatment in an HIV-positive population: A cohort study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    23. de Martino, M; Galli, L; Moriondo, M; Zazzi, M; Azzari, C; Peruzzi, M; Vierucci, A
      Dissociation of responses to highly active antiretroviral therapy: Notwithstanding virologic failure and virus drug resistance, both CD4(+) and CD8(+) T lymphocytes recover in HIV-1 perinatally infected children

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    24. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Pisapia, M; Delbeke, E
      Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    25. Maijgren-Steffensson, C; Sonnerborg, A; Vahlne, A; Britton, S; Larsson, S; Ahrlund-Richter, L
      Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1

      MOLECULAR THERAPY
    26. Dyrhol-Riise, AM; Stent, G; Rosok, BI; Voltersvik, P; Olofsson, J; Asjo, B
      The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissueduring highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    27. Dyrhol-Riise, AM; Ohlsson, M; Skarstein, K; Nygaard, SJT; Olofsson, J; Jonsson, R; Asjo, B
      T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    28. de Martino, M; Chiarelli, F; Moriondo, M; Torello, M; Azzari, C; Galli, L
      Restored antioxidant capacity parallels the immunologic and virologic improvement in children with perinatal human immunodeficiency virus infection receiving highly active antiretroviral therapy

      CLINICAL IMMUNOLOGY
    29. Gajdatsy, AD; Tay-Kearney, ML
      Microsporidial keratoconjunctivitis after HAART

      CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    30. Flepp, M; Schiffer, V; Weber, R; Hirschel, B
      Modern anti-HIV therapy

      SWISS MEDICAL WEEKLY
    31. Stolte, IG; Dukers, NHTM; de Wit, JBF; Fennema, JSA; Coutinho, RA
      Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART

      SEXUALLY TRANSMITTED INFECTIONS
    32. Du Pasquier, RA; Clark, KW; Smith, PS; Joseph, JT; Mazullo, JM; De Girolami, U; Letvin, NL; Koralnik, IJ
      JCV-specific cellular immune response correlates with a favorable clinicaloutcome in HIV-infected individuals with progressive multifocal leukoencephalopathy

      JOURNAL OF NEUROVIROLOGY
    33. Cinque, P; Pierotti, C; Vigano, MG; Bestetti, A; Fausti, C; Bertelli, D; Lazzarin, A
      The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy

      JOURNAL OF NEUROVIROLOGY
    34. De Luca, A; Giancola, ML; Ammassari, A; Grisetti, S; Cingolani, A; Larussa, D; Alba, L; Murri, R; Ippolito, G; Cauda, R; Monforte, AD; Antinori, A
      Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study

      JOURNAL OF NEUROVIROLOGY
    35. Gasnault, J; Kousignian, P; Kahraman, M; Rahoiljaon, J; Matheron, S; Delfraissy, JF; Taoufik, Y
      Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: Amonocenter observational study with clinical and JC virus load monitoring

      JOURNAL OF NEUROVIROLOGY
    36. Regazzi, MB; Seminari, E; Villani, P; Carriero, PL; Montagna, M; Marubbi, F; Maserati, R
      Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile

      JOURNAL OF CHEMOTHERAPY
    37. Calza, L; Manfredi, R; Marinacci, G; Briganti, E; Giuliani, R; Talo', S; Chiodo, F
      Role of gancyclovir and HAART administration in the treatment of a rare complication of HIV disease: Cytomegalovirus-associated Guillain-Barre syndrome

      JOURNAL OF CHEMOTHERAPY
    38. Garbuglia, AR; Zaccarelli, M; Calcaterra, S; Cappiello, G; Marini, R; Benedetto, A
      Dynamics of viral load in plasma and HIV DNA in lymphocytes during highly active antiretroviral therapy (HAART): High viral burden in macrophages after 1 year of treatment

      JOURNAL OF CHEMOTHERAPY
    39. Herlitz, CA; Steel, JL
      Highly active antiretroviral therapy (HAART) - Awareness and beliefs aboutinfectivity and the influence on sexual behaviour in the general population of Sweden

      EUROPEAN JOURNAL OF PUBLIC HEALTH
    40. Su, J; Andersson, E; Horai, P; Naghavi, MH; Palm, A; Wu, YP; Eriksson, K; Jansson, M; Wigzell, H; Svennerholm, B; Vahlne, A
      The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1

      JOURNAL OF HUMAN VIROLOGY
    41. Goodkin, K; Baldewicz, TT; Asthana, D; Khamis, I; Blaney, NT; Kumar, M; Burkhalter, JE; Leeds, B; Shapshak, P
      A bereavement support group intervention affects plasma burden of human immunodeficiency virus type 1 - Report of a randomized controlled trial

      JOURNAL OF HUMAN VIROLOGY
    42. Knobel, H; Guelar, A; Carmona, A; Espona, M; Gonzalez, A; Lopez-Colomes, JL; Saballs, P; Gimeno, JL; Diez, A
      Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors

      AIDS PATIENT CARE AND STDS
    43. Wislez, M; Bergot, E; Antoine, M; Parrot, A; Carette, MF; Mayaud, C; Cadranel, J
      Acute respiratory failure following HAART introduction in patients treatedfor Pneumocystis carinii pneumonia

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    44. Hadigan, C; Jeste, S; Anderson, EJ; Tsay, R; Cyr, H; Grinspoon, S
      Modifiable dietary habits and their relation to metabolic abnormalities inmen and women with human immunodeficiency virus infection and fat redistribution

      CLINICAL INFECTIOUS DISEASES
    45. Hadigan, C; Meigs, JB; Corcoran, C; Rietschel, P; Piecuch, S; Basgoz, N; Davis, B; Sax, P; Stanley, T; Wilson, PWF; D'Agostino, RB; Grinspoon, S
      Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

      CLINICAL INFECTIOUS DISEASES
    46. Chow, KU; Mitrou, PS; Geduldig, K; Helm, EB; Hoelzer, D; Brodt, HR
      Changing incidence and survival in patients with AIDS-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART)

      LEUKEMIA & LYMPHOMA
    47. Fraser, C; Ferguson, NM; de Wolf, D; Anderson, RM
      The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    48. Rabkin, CS
      AIDS and cancer in the era of highly active antiretroviral therapy (HAART)

      EUROPEAN JOURNAL OF CANCER
    49. Kocjan, G; Miller, R
      The cytology of HIV-induced immunosuppression. Changing pattern of diseasein the era of highly active antiretroviral therapy

      CYTOPATHOLOGY
    50. Arici, C; Ripamonti, D; Ravasio, V; Maggiolo, F; Rizzi, M; Finazzi, MG; Suter, F
      Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution

      INTERNATIONAL JOURNAL OF STD & AIDS
    51. Muise, A; Arbess, G
      The risk of myocardial infarction in HIV-infected patients receiving HAART: a case report

      INTERNATIONAL JOURNAL OF STD & AIDS
    52. Burgoyne, RW; Saunders, DS
      Quality of life among urban Canadian HIV/AIDS clinic outpatients

      INTERNATIONAL JOURNAL OF STD & AIDS
    53. Segal, R; Poznansky, MC; Connors, L; Sands, K; Barlam, T
      Changing patterns of presentations of patients with HIV-related disease ata tertiary referral centre and its implications for physician training

      INTERNATIONAL JOURNAL OF STD & AIDS
    54. Youle, M
      Salvage treatment in HIV disease

      INTERNATIONAL JOURNAL OF STD & AIDS
    55. Borges, LHB; Boas, LSV; Warren-Santoro, SH; Estevam, MP; Uip, DE; Savalli, C; Curi, M; Pannuti, CS
      Effect of highly active antiretroviral therapy on cytomegalovirus antigenaemia in AIDS patients

      INTERNATIONAL JOURNAL OF STD & AIDS
    56. Quah, SP; McBride, M
      A case of pneumocystis pneumonia after cessation of secondary prophylaxis

      INTERNATIONAL JOURNAL OF STD & AIDS
    57. Skiest, DJ; Chiller, T; Chiller, K; Park, A; Keiser, P
      Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis

      INTERNATIONAL JOURNAL OF STD & AIDS
    58. Zimmermann, T; Stingele, K; Hartmann, M; Haas, J; von Einsiedel, R; Wildemann, B
      Successful treatment of AIDS related PML with HAART and cidofovir

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    59. Casado, JL; Lopez-Velez, R; Pintado, V; Quereda, C; Antela, A; Moreno, S
      Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    60. Johnston, AM; Valentine, ME; Ottinger, J; Baydo, R; Gryszowka, V; Vavro, C; Weinhold, K; Clair, MS; McKinney, RE
      Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    61. Biggar, RJ
      AIDS-related cancers in the era of highly active antiretroviral therapy

      ONCOLOGY-NEW YORK
    62. Craiu, A; Barouch, DH; Zheng, XX; Kuroda, MJ; Schmitz, JE; Lifton, MA; Steenbeke, TD; Nickerson, CE; Beaudry, K; Frost, JD; Reimann, KA; Strom, TB; Letvin, NL
      An IL-2/Ig fusion protein influences CD4(+) T lymphocytes in naive and simian immunodeficiency virus-infected rhesus monkeys

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    63. Brechtl, JR; Breitbart, W; Galietta, M; Krivo, S; Rosenfeld, B
      The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: Impact on medical, palliative care, and quality of life outcomes

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    64. Mathe, G
      The failure of HARRT to cure the HIV-1/AIDS complex. Suggestions to add integrase inhibitors as complementary virostatics, and to replace their continuous long combination applications by short sequences differing by drug rotations.

      BIOMEDICINE & PHARMACOTHERAPY
    65. Hermans, P
      Current review and clinical management of patients with primary HIV-1 infection: limits and perspectives

      BIOMEDICINE & PHARMACOTHERAPY
    66. Pomerantz, RJ
      Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy

      BIOMEDICINE & PHARMACOTHERAPY
    67. Monforte, AD; Adorni, F; Meroni, L; Bini, T; Testa, L; Chiesa, E; Melzi, S; Rusconi, S; Sollima, S; Galli, M; Moroni, M
      Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen

      BIOMEDICINE & PHARMACOTHERAPY
    68. Gray, F; Adle-Biassette, H; Chretien, F; de la Grandmaison, GL; Force, G
      Neuropathology and neurodegeneration in human immunodeficiency virus infection - Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments

      CLINICAL NEUROPATHOLOGY
    69. Ruiz, L; Carcelain, G; Martinez-Picado, J; Frost, S; Marfil, S; Paredes, R; Romeu, J; Ferrer, E; Morales-Lopetegi, K; Autran, B; Clotet, B
      HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

      AIDS
    70. Grelli, S; Di Traglia, L; Matteucci, C; Lichtner, M; Vullo, V; Di Sora, F; Lauria, F; Montella, F; Favalli, C; Vella, S; Macchi, B; Mastino, A
      Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression

      AIDS
    71. Costa, P; Rusconi, S; Mavilio, D; Fogli, M; Murdaca, G; Pende, D; Mingari, MC; Galli, M; Moretta, L; De Maria, A
      Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes

      AIDS
    72. Lepri, AC; Phillips, AN; Monforte, AD; Castelli, F; Antinori, A; de Luca, A; Pezzotti, P; Alberici, F; Cargnel, A; Grima, P; Piscopo, R; Prestileo, T; Scalise, G; Vigevani, M; Moroni, M
      When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

      AIDS
    73. Duran, S; Solas, C; Spire, B; Carrieri, MP; Fuzibet, JG; Costagliola, D; Lacarelle, B; Moatti, JP
      'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports andserum protease inhibitor concentrations in the French Manif 2000 cohort study

      AIDS
    74. John, M; Moore, CB; James, IR; Nolan, D; Upton, RP; McKinnon, EJ; Mallal, SA
      Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

      AIDS
    75. Pernerstorfer-Schoen, H; Jilma, B; Perschler, A; Wichlas, S; Schindler, K; Schindl, A; Rieger, A; Wagner, OF; Quehenberger, P
      Sex differences in HAART-associated dyslipidaemia

      AIDS
    76. Cohen, RA; Boland, R; Paul, R; Tashima, KT; Schoenbaum, EE; Celentano, DD; Schuman, P; Smith, DK; Carpenter, CCJ
      Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women

      AIDS
    77. Detels, R; Tarwater, P; Phair, JP; Margolick, J; Riddler, SA; Munoz, A
      Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis

      AIDS
    78. Dukers, NHTM; Goudsmit, J; de Wit, JBF; Prins, M; Weverling, GJ; Coutinho, RA
      Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection

      AIDS
    79. Suarez, S; Baril, L; Stankoff, B; Khellaf, M; Dubois, B; Lubetzki, C; Bricaire, F; Hauw, JJ
      Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy

      AIDS
    80. Romiti, ML; Cancrini, C; Castelli-Gattinara, G; Di Cesare, S; Ciaffi, P; Bernardi, S; De Gasperi, MR; Halapi, E; Rossi, P
      Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART

      AIDS
    81. Grant, LA; Silverberg, MJ; Palacio, H; Minkoff, H; Anastos, K; Young, MA; Nowicki, M; Kovacs, A; Cohen, M; Munoz, A
      Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels

      AIDS
    82. Minkoff, H; Ahdieh, L; Massad, LS; Anastos, K; Watts, DH; Melnick, S; Muderspach, L; Burk, R; Palefsky, J
      The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women

      AIDS
    83. Toma, E; Devost, D; Lan, NC; Bhat, PV
      HIV-protease inhibitors alter retinoic acid synthesis

      AIDS
    84. Teixeira, L; Valdez, H; McCune, JM; Koup, RA; Badley, AD; Hellerstein, MK; Napolitano, LA; Douek, DC; Mbisa, G; Deeks, S; Harris, JM; Barbour, JD; Gross, BH; Francis, IR; Halvorsen, R; Asaad, R; Lederman, MM
      Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function

      AIDS
    85. Mora, S; Sala, N; Bricalli, D; Zuin, G; Chiumello, G; Vigano, A
      Bone mineral loss through increased bone turnover in HIV-infected childrentreated with highly active antiretroviral therapy

      AIDS
    86. Lew, E; Gallagher, L; Kuehnert, M; Rimland, D; Hubbard, M; Parekh, B; Zell, E; Jarvis, W; Jason, J
      Intracellular cytokines in the acute response to highly active antiretroviral therapy

      AIDS
    87. Antela, A
      Access to antiretroviral therapy in HIV infected injection drug users

      AIDS
    88. Dorrucci, M; Pezzotti, P; Grisorio, B; Minardi, C; Muro, MS; Vullo, V; Monforte, AD
      Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens

      AIDS
    89. Antinori, A; Cingolani, A; Alba, L; Ammassari, A; Serraino, D; Ciancio, BC; Palmieri, F; De Luca, A; Larocca, LM; Ruco, L; Ippolito, G; Cauda, R
      Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

      AIDS
    90. Birk, M; Svedhem, V; Sonnerborg, A
      Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy

      AIDS
    91. Pomerantz, RJ
      Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence

      AIDS
    92. Nolan, D; Upton, R; McKinnon, E; John, M; James, I; Adler, B; Roff, C; Vasikaran, S; Mallal, S
      Stable or increasing bone mineral density in HIV-infected patients treatedwith nelfinavir or indinavir

      AIDS
    93. Blower, S
      Calculating the consequences: HAART and risky sex

      AIDS
    94. Saag, MS
      The impact of highly active antiretroviral therapy on HIV-specific immune function

      AIDS
    95. Lederman, MM
      Immune restoration and CD4+T-cell function with antiretroviral therapies

      AIDS
    96. Norris, PJ; Rosenberg, ES
      Cellular immune response to human immunodeficiency virus

      AIDS
    97. Bucy, RP; Kilby, JM
      Perspectives on inducing efficient immune control of HIV-1 replication - anew goal for HIV therapeutics?

      AIDS
    98. Caggiari, L; Zanussi, S; Crepaldi, C; Bortolin, MT; Caffau, C; D'Andrea, M; De Paoli, P
      Different rates of CD4+and CD8+T-cell proliferation in interleukin-2-treated human immunodeficiency virus-positive subjects

      CYTOMETRY
    99. Rodriguez-Rosado, R; Perez-Olmeda, M; Garcia-Samaniego, J; Soriano, V
      Management of hepatitis C in HIV-infected persons

      ANTIVIRAL RESEARCH
    100. Jain, RG; Furfine, ES; Pedneault, L; White, AJ; Lenhard, JM
      Metabolic complications associated with antiretroviral therapy

      ANTIVIRAL RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/04/20 alle ore 22:45:46